STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

Canopy Growth Corp Stock Price, News & Analysis

CGC Nasdaq

Welcome to our dedicated page for Canopy Growth news (Ticker: CGC), a resource for investors and traders seeking the latest updates and insights on Canopy Growth stock.

Canopy Growth Corporation (CGC) is a global leader in cannabis production and consumer goods innovation. This news hub provides investors and industry observers with official press releases, financial updates, and strategic developments from one of the sector's most diversified companies.

Access real-time updates on CGC's medicinal cannabis research, recreational product launches, and international market expansions. Our curated collection includes earnings reports, partnership announcements, and regulatory compliance milestones across Canada, Europe, and U.S. markets through Canopy USA.

Key focus areas include vaporizer technology advancements, brand portfolio growth, and cultivation process innovations. Users will find detailed information on THC and CBD product developments, sustainability initiatives, and strategic moves in emerging cannabis markets.

Bookmark this page for direct access to verified CGC announcements. Check regularly for updates on clinical trials, retail partnerships, and operational developments that shape the company's position in the global cannabis industry.

Rhea-AI Summary

Canopy Growth (NASDAQ:CGC) reported Q2 FY2026 results for the quarter ended September 30, 2025, showing sequential and year‑over‑year improvement across several metrics.

Key highlights: consolidated net revenue $67MM (+6% YoY); cannabis revenue $51MM (+12% YoY); Canada adult‑use $24MM (+30% YoY); Canada medical $22MM (+17% YoY). Cash and cash equivalents were $298MM, exceeding debt by $70MM, resolving prior going‑concern doubts. Q2 operating loss improved to $17MM (‑63% YoY) and Adjusted EBITDA loss narrowed to $3MM. The company reported margin headwinds from lower international sales and inventory provisions but captured $21MM of annualized cost savings since March 1, 2025.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
7.34%
Tags
-
Rhea-AI Summary

Canopy Growth (NASDAQ:CGC, TSX:WEED) will release its second quarter fiscal 2026 financial results for the period ended September 30, 2025 before markets open on November 7, 2025.

Management will host a live audio webcast with Luc Mongeau, CEO, and Tom Stewart, CFO on November 7, 2025 at 10:00 AM ET. A live webcast link and a replay accessible through February 5, 2026 at 11:59 PM ET are provided.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.27%
Tags
conferences earnings
-
Rhea-AI Summary

Canopy Growth (Nasdaq: CGC) reported voting results from its Annual General and Special Meeting reconvened on October 10, 2025. All matters in the company proxy were approved by the requisite votes.

Key items approved include election of all director nominees (each elected to serve until the next annual meeting), re-appointment of PKF O’Connor Davies as auditors for the fiscal year ending March 31, 2026, an advisory vote on named executive officer compensation, and an amendment authorizing a potential share consolidation that the board may implement within 12 months or let lapse.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.73%
Tags
none
Rhea-AI Summary

Canopy Growth (Nasdaq: CGC) announced that its DOJA facility in Kelowna, BC is now operating exclusively as a medical cultivation site supporting the company's Spectrum Therapeutics portfolio as of October 8, 2025. The site will produce small-batch, BC-grown craft cannabis under the DOJA brand that will be available only to registered Spectrum Therapeutics medical patients, including veterans. The facility operates under a new micro-cultivation license and has been upgraded to deliver consistent, high-quality flower and support product development within Spectrum's medical lineup.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
5.52%
Tags
none
-
Rhea-AI Summary

JP Brand Advisors and Canopy USA announced a strategic partnership on October 7, 2025 to expand U.S. distribution of Wana Wellness hemp-based beverages and gummies. The agreement assigns JP Brand Advisors to support distributor management and strategic account growth while leveraging Canopy USA's cannabis-market distribution footprint. The partnership targets growth in the non-alcoholic, functional and hemp-infused beverage segment amid rising retailer and distributor interest and greater regulatory clarity in key markets.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
4.32%
Tags
partnership
-
Rhea-AI Summary

Canopy Growth (NASDAQ:CGC) has announced the adjournment of its Annual General and Special Meeting of Shareholders due to insufficient quorum. The meeting, originally scheduled for September 26, 2025, has been rescheduled to October 10, 2025 at 1:00 PM ET via live webcast.

The company requires 33 1/3% of outstanding shares to be represented for quorum, as per NASDAQ listing requirements. Shareholders of record as of August 1, 2025 are eligible to vote, and the voting deadline has been extended to October 8, 2025. The company has retained Laurel Hill Advisory Group to assist shareholders with the voting process.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.19%
Tags
none
Rhea-AI Summary

Canopy Growth (NASDAQ:CGC) has extended the proxy voting deadline for its upcoming Annual General and Special Meeting to September 26, 2025 at 9:00 AM ET. The Meeting will be held the same day at 1:00 PM ET via live audio webcast. The extension aims to ensure a quorum of 33 1/3% of outstanding shares, required by NASDAQ listing rules.

CEO Luc Mongeau indicated they are close to achieving quorum and encouraged remaining shareholders to participate. The company has retained Laurel Hill Advisory Group to assist shareholders with voting, which can be done online, by phone, or through various platforms depending on where shares are held.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
8.4%
Tags
none
-
Rhea-AI Summary

Canopy Growth (NASDAQ:CGC) is urging shareholders to vote ahead of their Annual General and Special Meeting scheduled for September 26, 2025. The company needs to reach a quorum threshold of 33 1/3% of outstanding shares to maintain its NASDAQ listing requirements and avoid meeting delays and additional costs.

Shareholders of record as of August 1, 2025 are eligible to vote, with a proxy voting deadline of September 24, 2025 at 1:00 PM ET. The Board of Directors recommends voting FOR all proposals. Multiple voting options are available through Broadridge, Interactive Brokers, Robinhood, or through the company's proxy solicitation agent, Laurel Hill Advisory Group.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.72%
Tags
none
-
Rhea-AI Summary

Canopy Growth (Nasdaq: CGC) has appointed Tom Stewart as permanent Chief Financial Officer, effective immediately. Stewart, who has served as Interim CFO since July 2025 and has been part of the company's senior finance leadership since 2019, will focus on executing Canopy Growth's fiscal year 2026 strategy.

Under Stewart's interim leadership, the company has made progress in stabilizing its financial position through debt repayments, cost reduction initiatives, and capital raising via ATM programs. The appointment aligns with Canopy Growth's emphasis on operational discipline, financial stability, and long-term value creation.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-6.21%
Tags
none
Rhea-AI Summary

Canopy Growth (Nasdaq: CGC) has completed an early prepayment of US$25 million on its senior secured term loan, following a previous US$25 million payment made on July 31, 2025. This fulfills the company's total prepayment obligations of US$50 million under the agreement with lenders announced on July 29, 2025.

The accelerated debt reduction is expected to result in US$6.5 million in annual cash interest savings, with US$4.0 million of cash interest savings specifically for fiscal 2026. The early completion of these prepayments demonstrates the company's commitment to strengthening its financial position through debt reduction and interest expense management.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.46%
Tags
none

FAQ

What is the current stock price of Canopy Growth (CGC)?

The current stock price of Canopy Growth (CGC) is $1.2 as of November 11, 2025.

What is the market cap of Canopy Growth (CGC)?

The market cap of Canopy Growth (CGC) is approximately 434.6M.
Canopy Growth Corp

Nasdaq:CGC

CGC Rankings

CGC Stock Data

434.59M
311.42M
0.07%
7.26%
6.76%
Drug Manufacturers - Specialty & Generic
Medicinal Chemicals & Botanical Products
Link
Canada
SMITH FALLS